Probiotics in irritable bowel syndrome: underachievers or underpowered? authors’ reply
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Sirs, We wish to thank Dr Ford for his interest1 in our recent article published in APT.2 In essence, we agree with the comments made by Dr Ford, and a very likely explanation for the lack of statistical significance between the active treatment group and the control group is that the study was under-powered. However, we have to stress that our assumption of the placebo response rate (15%), using our responder definition, is closer to the observed placebo response in our study (27%), than the pooled placebo response rate from the recent systematic review (43%),3 mentioned by Dr Ford in his letter. Therefore, the incorrect assumption of the placebo response rate does not seem to be a major explanation behind the lack of a statistical difference between the groups. To conclude, we agree that larger studies are needed to assess the effect of probiotics in IBS, to obtain a response to the question posed in the letter by Dr Ford: ‘Probiotics in IBS: underachievers or underpowered?’ We tend to believe that underpowered studies contribute to some of the negative results in the literature, but differences between probiotic products are also of potential importance. Declaration of personal interests: Magnus Simrén has served as a speaker or advisor for AstraZeneca, Novartis, Albireo, Danone, Movetis Addex and Succampo, and has received research funding from AstraZeneca and Danone. Johan Olsson is an employee of KPL Good Food Practice. Ulla Svensson and Kajsa Ohlson are employees of Arla Foods Innovation. Declaration of funding interests: The original study was supported by an unrestricted grant from Arla Foods Innovation, Stockholm, Sweden to the department of Internal Medicine, Sahlgrenska University Hospital, Sweden. This study was supported by the Swedish Medical Research Council (grant 13409), and by the Faculty of Medicine, University of Göteborg.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SIMRÉN, M., ÖHMAN, L., OLSSON, J., SVENSSON, U., OHLSON, K., POSSERUD, I., & STRID, H. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04183.x · Cited by 169
Self-citationDorn, S. D., Kaptchuk, T. J., Park, J. B., Nguyen, L. T., Canenguez, K., Nam, B. H., Woods, K. B., Conboy, L. A., Stason, W. B., & Lembo, A. J. (2007) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2007.00937.x · Cited by 119
Cited by
Ford, A. C., Quigley, E. M. M., Lacy, B. E., Lembo, A. J., Saito, Y. A., Schiller, L. R., Soffer, E. E., Spiegel, B. M. R., & Moayyedi, P. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.202 · Cited by 747
Ford, A. C., Moayyedi, P., Lacy, B. E., Lembo, A. J., Saito, Y. A., Schiller, L. R., Soffer, E. E., Spiegel, B. M. R., & Quigley, E. M. M. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.187 · Cited by 645
Microbiota-Gut-Brain Axis: New Therapeutic Opportunities
Long-Smith, C., O'Riordan, K. J., Clarke, G., Stanton, C., Dinan, T. G., & Cryan, J. F. (2020) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010919-023628 · Cited by 419
American College of Gastroenterology Monograph on Management of Irritable Bowel Syndrome
Ford, A. C., Moayyedi, P., Chey, W. D., Harris, L. A., Lacy, B. E., Saito, Y. A., & Quigley, E. M. M. (2018) · American Journal of Gastroenterology · doi:10.1038/s41395-018-0084-x · Cited by 388
Ki Cha, B., Mun Jung, S., Hwan Choi, C., Song, I.-D., Woong Lee, H., Joon Kim, H., Hyuk, J., Kyung Chang, S., Kim, K., Chung, W.-S., et al. (2012) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31823712b1 · Cited by 216
Metadata
- Authors
- Simrén, M., ÖHman, L., Olsson, J., Svensson, U., Ohlson, K., Posserud, I., & Strid, H.
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2010-03-17
- Volume
- 31
- Issue
- 8
- Pages
- 923-924
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- OpenAlex
- W1803376482
- Cited by
- 23
- References
- 2
- FWCI
- 3.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Probiotics in irritable bowel syndrome: underachievers or underpowered? authors’ reply. https://app.cochat.ai/papers/10.1111/j.1365-2036.2010.04239.x
- The paper
- Simrén, M., ÖHman, L., Olsson, J., Svensson, U., Ohlson, K., Posserud, I., & Strid, H. (2010). Probiotics in irritable bowel syndrome: underachievers or underpowered? authors’ reply. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.2010.04239.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.